Webinar 27
When COVID-19 emerged in year 2020, there was an immediate need to understand COVID-19 outcomes among individuals with sickle cell disease (SCD).
When COVID-19 emerged in year 2020, there was an immediate need to understand COVID-19 outcomes among individuals with sickle cell disease (SCD).
Addressing School-Related Inequities for Individuals Living with Sickle Cell Disease During the COVID-19 Pandemic and Beyond
This presentation will give a broad overview of the perceived hesitations, current data, and future direction of physical activity in sickle cell disease.
Claudine Mathews from the UK’s National Health Service, talks about nutrition. Integrating Nutrition as a management option in Sickle Cell Disease: A Call to Action
Community Engaged Education Materials for SCD Gene Therapy
Cayenne Wellness Center, Sickle Cell Consortium Axis Advocacy and SCAASF FREE AND OPEN TO THE ENTIRE SICKLE CELL COMMUNITY
New Data from CA SCDC: Sickle Cell Disease Activities October 2020 – January 2021
Advancing World-Class Science and Patient Engagement: CIRM’s Sickle Cell Disease Portfolio CIRM’s research programs.
The Consortium of Health and Military Performance (CHAMP), Uniformed Services University (USU) is conducting a study to better understand the association between SCT and EREs. This study will search for genetic markers of EREs in individuals with SCT.
End-of-Life Healthcare Utilization in Sickle Cell Disease and thePalliative Care Model